ZUG, Switzerland and BOSTON, Feb. 11, 2025 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious ...

Willow Biosciences Inc. logo ... strategic alternatives with a view to maximizing and accelerating the value of Willow's assets. Strategic alternatives may include, but are not limited to ...

Q4 2024 Earnings Call Transcript February 13, 2025 CyberArk Software Ltd. beats earnings expectations. Reported EPS is $0.8, expectations were $0.71. Operator: Good morning, my name is Aaron and I ...

Nava Limited, a leading conglomerate with business interests in metals, energy, mining, commercial agriculture, and ...

Strategic Financial Concepts LLC acquired a new stake in shares of Chubb Limited (NYSE:CB – Free Report) during the 4th quarter, Holdings Channel.com reports. The fund acquired 10,873 shares of the ...

THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, BRITISH COLUMBIA / ACCESS ...

In a report released today, Steven Sassine from Morgans maintained a Buy rating on Seek Limited (SKLTF – Research Report), with a price target ...

At Aero India 2025, BEML Ltd showcases its latest advancements in aerospace, defence, and strategic engineering, reinforcing ...

president of 42West’s Strategic Communications Division. “His command of the macro and micro issues facing the broad entertainment, media, and financial industries is a tremendous boon for our ...

The most notable increase was Teva Pharmaceutical Industries Ltd (NYSE:TEVA), with an additional 7,569,450 shares, bringing the total to 8,997,400 shares. This adjustment represents a significant ...

It sparked an intense discussion. On the one hand, the company had been delivering impressive financial results for nearly two years, exceeding both internal plans and analysts’ expectations.